Dose-dependent duration is a PK→PD construct describing how changes in a modeled dose parameter modify concentration-time geometry and therefore the modeled duration window. Dose is not a clinical instruction; it is a model input that can scale peak height, rising-phase slope, distribution loading, and early-phase turnover. A larger modeled dose parameter can produce a higher peak and broader early-phase geometry, while a smaller parameter can produce lower concentration trajectories and narrower geometry. Duration emerges from decline-phase persistence, redistribution timing, and threshold placement, not from peak height alone. Consequently, increasing the modeled dose parameter may extend, compress, or leave the calculated duration interval largely unchanged, depending on how concentration geometry intersects the PD interpretation layer. The same parameter change can therefore generate different duration shifts under different PK and PD assumptions. This page describes those relationships for modeled sildenafil trajectories without assigning clinical meaning to any dose value. Link to duration basics.
PK mechanisms determine how a modeled dose parameter changes sildenafil concentration-time geometry before any PD interpretation is applied. Increasing the parameter can raise peak height, increase distribution loading, and alter the amount of material entering peripheral compartments during the early trajectory. These changes can modify the subsequent decline shape because concentration available for metabolism and elimination is distributed across multiple kinetic processes. If metabolic or elimination turnover is represented as concentration-dependent, the resulting decline may become steeper at higher modeled concentrations rather than scaling proportionally. If turnover remains approximately linear, the trajectory may retain a similar shape while shifting upward. Redistribution timing adds another dimension: deeper compartment loading can contribute to a more extended return phase, whereas limited loading can leave the later trajectory more directly governed by elimination. Thus, modeled dose does not independently determine duration; it modifies the initial conditions from which distribution, metabolism, and elimination generate the persistence geometry. Link to distribution differences and metabolism differences.
PD mechanisms determine how dose-dependent concentration trajectories are converted into modeled duration intervals. Threshold placement controls whether a higher modeled trajectory crosses a boundary earlier and remains above it longer, or instead traverses a steep interpretation region where temporal differences remain relatively compressed. Binding sensitivity determines how concentration changes are transformed into a binding coordinate; high sensitivity can magnify separation between modeled dose trajectories, whereas lower sensitivity can compress that separation. Coupling geometry then maps binding into a downstream PD coordinate, with local slope determining whether concentration differences expand or contract before threshold comparison. PD noise bands broaden transition regions and can reduce the precision of a single crossing coordinate. Consequently, two dose-scaled PK trajectories can generate distinct duration windows under one PD mapping but similar windows under another. Dose-dependent duration is therefore a property of the complete PK→PD transformation, including threshold location, binding sensitivity, coupling slope, and noise-band width. Link to peak vs duration.
A modeled sildenafil dose parameter primarily changes the scale and initial geometry of the concentration trajectory. Increasing that parameter can raise peak concentration, increase the rising-phase amplitude, and increase distribution loading into peripheral compartments. The magnitude of each change depends on the absorption and distribution structure specified by the model. A higher peak does not automatically imply a proportionally longer modeled duration because the relevant boundary may be reached on either the rising or declining limb. Distribution loading can alter the later trajectory by increasing the contribution of peripheral compartments during redistribution. If intercompartmental transfer is sufficiently slow, this contribution can flatten the terminal region; if transfer is rapid, the later trajectory can remain dominated by central-compartment decline. Thus, dose-dependent persistence depends on how peak scaling interacts with compartmental geometry rather than on peak height in isolation. Link to absorption duration.
Metabolism and elimination determine how the dose-scaled concentration trajectory loses magnitude after distribution. Under linear turnover, changing the modeled dose parameter can primarily shift concentration upward while preserving characteristic rate constants, so duration boundaries may move according to threshold geometry rather than a proportional change in persistence. Under concentration-dependent turnover, higher modeled concentrations can encounter different effective clearance behavior, changing the slope and curvature of the decline. Metabolic conversion can also redistribute material between parent and metabolite trajectories, altering which component contributes to the modeled concentration coordinate. Elimination then determines the terminal rate at which the remaining concentration approaches the selected PD boundary. These processes can interact nonlinearly: increased loading may extend the concentration range traversed during decline, while altered turnover can simultaneously steepen that decline. Consequently, dose-dependent duration is governed by the combined response of metabolism and elimination, not by dose scaling alone. Link to metabolism duration.
| PK Domain | Dose Effect | Link |
|---|---|---|
| Peak Height | Larger modeled dose parameter → higher peak. | peak vs duration |
| Distribution Loading | Larger modeled dose parameter → deeper modeled loading. | distribution duration |
| Elimination | Modeled concentration-dependent decline can alter slope. | half-life duration |
Threshold placement determines how differences between dose-scaled concentration trajectories become differences in modeled duration. If a threshold is positioned below both trajectories across much of the decline, the higher modeled trajectory may remain above that boundary for a longer calculated interval. If the threshold is placed near a steep section of the concentration curve, relatively small changes in concentration can create substantial shifts in the corresponding crossing coordinate. Multiple thresholds can further separate entry and exit behavior, allowing the same dose parameter change to affect the two boundaries differently. A threshold positioned near the peak can primarily reflect rising-phase and distribution geometry, while a lower threshold can emphasize terminal persistence and elimination. Therefore, the relationship between modeled dose and duration cannot be defined from peak height alone. It depends on where the PD boundary intersects each dose-scaled trajectory and on the local slope at those intersections. Link to onset–duration interaction.
Binding sensitivity and coupling geometry determine how dose-related concentration differences propagate through the PD interpretation layer. A sensitive binding function can transform a relatively small separation between dose-scaled PK trajectories into a larger separation in the modeled binding coordinate. A less sensitive function can compress the same concentration difference. Coupling geometry then determines how that binding coordinate maps into the downstream PD representation. A steep local coupling slope can expand differences near a boundary, whereas a shallow slope can compress them. PD noise bands introduce additional width around the transition and can make calculated duration boundaries appear as ranges rather than single coordinates. These transformations can either amplify or reduce the temporal separation generated by PK dose scaling. Consequently, two models with identical dose-dependent PK trajectories can produce different duration intervals when their binding, coupling, threshold, or noise assumptions differ. The dose parameter therefore affects duration only through the complete PK→PD mapping. Link to duration stability.
| PD Domain | Dose Interaction | Link |
|---|---|---|
| Threshold Placement | Earlier or later modeled boundary crossing. | peak vs duration |
| Binding Sensitivity | Can amplify dose-trajectory differences. | duration stability |
| Coupling Geometry | Slope-driven expansion or compression. | duration predictability |
For sildenafil, a modeled dose parameter can produce comparatively strong changes in calculated duration when the PK parameter set combines a pronounced peak shift with relatively rapid terminal elimination. Under those assumptions, increasing the modeled concentration scale moves the trajectory farther from a selected PD boundary, but the relatively steep decline can also cause the trajectory to traverse that boundary rapidly. Consequently, duration may change substantially over some threshold placements while remaining comparatively compressed under others. Distribution loading can modify this pattern by adding peripheral persistence to the later trajectory, but the magnitude depends on intercompartmental transfer and elimination parameters. The resulting dose–duration curve is therefore not required to be linear. Its shape reflects the interaction between dose-scaled concentration, redistribution, metabolic turnover, terminal elimination, and the position of the PD boundary. The relevant comparison is between modeled parameter sets rather than between real-world dose levels or observed responses. Link to 4–6 hour window.
For tadalafil-oriented models, a dose parameter can produce shallower changes in calculated duration when slower elimination and extended redistribution generate a flatter later concentration trajectory. Under those assumptions, changing the modeled concentration scale can shift the trajectory relative to a PD boundary while the terminal region remains less steep. This can reduce temporal sensitivity of the boundary to concentration changes over selected parameter ranges. Extended redistribution can also maintain peripheral contribution during the later phase, creating a broader persistence geometry than a model dominated by rapid terminal decline. However, shallow scaling is not guaranteed: threshold placement, nonlinear turnover assumptions, binding sensitivity, and coupling geometry can change the relationship between dose parameter and calculated duration. The important distinction is that the model's rate constants and compartmental structure determine trajectory shape, while the dose parameter sets its initial scale. The resulting interval remains a mathematical PK→PD construct rather than a real-world dose–duration relationship. Link to tadalafil 36-hour window.
PK→PD mapping can amplify or compress modeled dose–duration differences after the dose parameter has altered the concentration trajectory. Suppose two modeled dose values produce separated concentration curves. If the binding function is highly sensitive near the relevant concentration range and the coupling function has a steep local slope, the separation can become larger in the transformed PD coordinate. A threshold may then be crossed at substantially different modeled times. If binding sensitivity is lower or coupling is shallow, the same PK separation can be compressed before threshold comparison. Noise bands can further broaden the transition and reduce the meaning of a single exact crossing coordinate. This means that a steep PK dose–duration relationship can become less pronounced under a compressive PD mapping, while modest PK scaling can become more prominent under an amplifying mapping. Dose therefore acts through a chain of transformations rather than directly specifying duration. Link to pkpd duration.
| Compound | Dose Behavior | Duration Behavior | Link |
|---|---|---|---|
| Sildenafil | Modeled dose scaling can produce steep trajectory separation. | Boundary interval depends strongly on decline geometry. | why sildenafil wears off |
| Tadalafil | Modeled dose scaling can produce shallower trajectory separation. | Boundary interval depends strongly on redistribution geometry. | why cialis lasts longer |
| Mapping | Can amplify or compress PK differences. | Changes calculated duration separation. | pkpd duration |
In a PK→PD model, dose is a parameter that changes the scale and initial geometry of the sildenafil concentration trajectory. Changing it can alter peak height, rising-phase slope, distribution loading, and the amount of concentration available for subsequent metabolism and elimination. The resulting duration interval is determined by where the dose-scaled trajectory intersects a specified PD boundary. A larger modeled dose parameter can shift that intersection later on the declining trajectory, but the temporal change is not necessarily proportional to the parameter change. Steep elimination, redistribution, nonlinear turnover, and threshold location can all modify the relationship. Therefore, dose does not directly define modeled duration. It changes the PK starting conditions, after which distribution, metabolism, elimination, binding, coupling, and threshold geometry determine the calculated interval.
The main PK mechanisms are peak formation, absorption geometry, distribution loading, redistribution, metabolic turnover, and elimination. A modeled dose parameter can increase the magnitude of the concentration trajectory and the amount entering peripheral compartments. Distribution then determines how that material moves between compartments, which can alter the later concentration slope. Metabolism controls turnover through parent and metabolite pathways, while elimination determines the terminal decline. Under linear kinetics, changing the modeled dose parameter may primarily scale concentrations without substantially changing rate constants. Under nonlinear assumptions, concentration-dependent turnover can change trajectory slope or curvature as the parameter changes. Duration is therefore produced by the combined geometry of these processes. No single PK quantity, including peak height or half-life, independently determines the modeled duration interval.
PD mechanisms modify dose-dependent duration by transforming concentration differences into interpretation differences. Threshold placement determines which section of the dose-scaled PK trajectory controls the boundary crossing. Binding sensitivity controls how strongly concentration changes alter the modeled binding coordinate. Coupling geometry determines how the binding coordinate is transformed into a downstream PD coordinate, with local slope controlling expansion or compression. PD noise bands add width around the transition and can make a boundary represent a range rather than one exact time. These layers can amplify or compress differences generated by the PK model. For example, two dose-scaled trajectories can remain widely separated in concentration while becoming closer after a compressive PD mapping. Conversely, modest concentration differences can become more separated under sensitive binding and steep coupling. Duration therefore depends on the complete interpretation chain.
A steep dose–duration relationship can arise in a sildenafil model when changes in the dose parameter substantially separate concentration trajectories while the terminal decline remains relatively steep. Under those assumptions, the dose parameter changes peak height and distribution loading, but elimination and metabolic turnover can cause the trajectories to converge rapidly during the later phase. Whether this produces a large or small duration shift depends on threshold placement. A boundary intersecting a steep region can be highly sensitive to concentration changes, while another boundary may show less temporal displacement. Distribution can also modify the later slope through peripheral persistence. Thus, steep scaling is not an intrinsic rule imposed by the dose parameter. It emerges from the selected PK rate constants, compartmental structure, turnover assumptions, and PD interpretation geometry. It remains a modeled relationship rather than a real-world dose–duration claim.
A shallow dose–duration relationship can arise in a tadalafil model when slower elimination and extended redistribution produce a flatter later concentration trajectory across modeled parameter sets. Changing the dose parameter can then shift concentration magnitude without producing an equally large displacement in the time at which a selected PD boundary is crossed. Peripheral persistence can contribute to this geometry by extending the redistribution phase and reducing dependence on a single steep terminal segment. However, shallow scaling is conditional rather than universal. Threshold placement can move the boundary onto a more sensitive part of the trajectory, while binding sensitivity and coupling slope can amplify concentration differences after PK transformation. Nonlinear turnover assumptions can also alter the relationship. Therefore, shallow dose–duration scaling describes a particular PK→PD geometry in a model and does not establish a real-world relationship between dose and duration.